The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Company Logo Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The International ...

Nautilus Biotechnolgy ( ($NAUT) ) has shared an update. On January 27 and 28, 2025, Vijay Pande and Michael Altman informed ...

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

H.C. Wainwright reaffirmed a Buy rating on Oncolytics Biotech (NASDAQ:ONCY) shares with a steady price target of $5.00. The stock, currently trading at $0.73 and near its 52-week low, shows potential ...

The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of ...